C(OC(=O)[NH:7][C:8]1[O:9][C@H:10]2[C@@H:12]([C@:13]([C:18]3[CH:23]=[C:22]([NH:24][C@H:25]([C:30]4[CH:35]=[CH:34][C:33]([Cl:36])=[CH:32][N:31]=4)[C:26]([F:29])([F:28])[F:27])[CH:21]=[CH:20][C:19]=3[F:37])([CH:15]([F:17])[F:16])[N:14]=1)[CH2:11]2)(C)(C)C.C(OC(=O)[NH:45][C:46]1[O:47][C@H:48]2[C@@H:50]([C@:51]([C:56]3[CH:61]=[C:60]([NH:62][C@@H:63]([C:68]4[CH:73]=[CH:72][C:71]([Cl:74])=[CH:70][N:69]=4)[C:64]([F:67])([F:66])[F:65])[CH:59]=[CH:58][C:57]=3[F:75])([CH:53]([F:55])[F:54])[N:52]=1)[CH2:49]2)(C)(C)C.FC(F)(F)C(O)=O>C(Cl)Cl>[Cl:36][C:33]1[CH:34]=[CH:35][C:30]([C@@H:25]([NH:24][C:22]2[CH:21]=[CH:20][C:19]([F:37])=[C:18]([C@:13]3([CH:15]([F:16])[F:17])[C@@H:12]4[C@@H:10]([CH2:11]4)[O:9][C:8]([NH2:7])=[N:14]3)[CH:23]=2)[C:26]([F:27])([F:28])[F:29])=[N:31][CH:32]=1.[Cl:74][C:71]1[CH:72]=[CH:73][C:68]([C@H:63]([NH:62][C:60]2[CH:59]=[CH:58][C:57]([F:75])=[C:56]([C@:51]3([CH:53]([F:54])[F:55])[C@@H:50]4[C@@H:48]([CH2:49]4)[O:47][C:46]([NH2:45])=[N:52]3)[CH:61]=2)[C:64]([F:65])([F:66])[F:67])=[N:69][CH:70]=1To a solution of tert-butyl((1R,5S,6R)-5-(5-(((R)-1-(5-chloropyridin-2-yl)-2,2,2-trifluoroethyl)amino)-2-fluorophenyl)-5-(difluoromethyl)-2-oxa-4-azabicyclo[4.1.0]hept-3-en-3-yl)carbamate and tert-butyl((1R,5S,6R)-5-(5-(((S)-1-(5-chloropyridin-2-yl)-2,2,2-trifluoroethyl)amino)-2-fluorophenyl)-5-(difluoromethyl)-2-oxa-4-azabicyclo[4.1.0]hept-3-en-3-yl)carbamate (1:1 mixture of diastereomers, 0.070 g, 0.12 mmol) in DCM (2 mL) at room temperature was added trifluoroacetic acid (2.00 mL, 0.124 mmol). The reaction mixture was stirred at room temperature for 30 min and concentrated. The concentrate was partitioned between saturated NaHCO3 and EtOAc. The aqueous phase was discarded. The organic phase was washed with brine and dried over MgSO4. The filtrate was concentrated under reduced pressure and the residue was purified by flash column chromatography on silica gel (12 g, 20% to 60% EtOAc in heptane) to give (1R,5S,6R)-5-(5-(((R)-1-(5-chloropyridin-2-yl)-2,2,2-trifluoroethyl)amino)-2-fluorophenyl)-5-(difluoromethyl)-2-oxa-4-azabicyclo[4.1.0]hept-3-en-3-amine and (1R,5S,6R)-5-(5-(((S)-1-(5-chloropyridin-2-yl)-2,2,2-trifluoroethyl)amino)-2-fluorophenyl)-5-(difluoromethyl)-2-oxa-4-azabicyclo[4.1.0]hept-3-en-3-amine (1:1 mixture of diastereomers, 0.056 g, 0.120 mmol, 97% yield) as a white solid. MS m/z=465.0 [M+H]+. Calculated for C19H15ClF6N4O 464.1. 1H NMR (400 MHz, CDCl3) δ 0.86-0.95 (m, 1H), 1.32-1.41 (m, 1H), 1.73-1.85 (m, 1H), 3.83-3.90 (m, 1H), 4.50 (br s, 2H), 4.87-4.97 (m, 1H), 5.33 (dd, J=11.93, 7.63 Hz, 1H), 6.02-6.34 (m, 1H), 6.60-6.66 (m, 1H), 6.87-6.96 (m, 2H) 7.27-7.35 (m, 1H), 7.65-7.70 (m, 1H), 8.57-8.59 (m, 1H).
読み込み中…